COVID-19 Progression in End-Stage Kidney Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey Connaire, MD
Davita Clinical Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dcr Victorville
Victorville, California, United States
- Dcr Connecticut
Bridgeport, Connecticut, United States
- Dcr Twin Cities
Minneapolis, Minnesota, United States
- Dcr Las Vegas
Las Vegas, Nevada, United States
- Dcr Bronx
The Bronx, New York, United States
- Dcr Canton
Canton, Ohio, United States
- Dcr El Paso
El Paso, Texas, United States
- Dcr Lewisville
Lewisville, Texas, United States
- Dcr San Antonio
San Antonio, Texas, United States
- Dcr Norfolk
Norfolk, Virginia, United States
- Dcr Milwaukee
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Aug 2020
- Primary completion
- 9 Apr 2021
- Completion
- 31 Aug 2021
- Last update posted
- 22 Mar 2022
- Registered enrollment
- 412
- Registry id
- NCT04495907
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.